Mologen AG: Patent For DNA Based Vaccine Against Important Cat Disease Granted

The European Patent Office has informed MOLOGEN AG (ISIN DE0006637200), that the patent for the DNA-vaccine against oncoviruses was granted. Corresponding applications outside the European Union are pending before national patent offices.